Publications by authors named "Robert Belt"

Claim this Profile
A
A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma.
Francine Foss, Ranjana Advani, Madeleine Duvic, Kenneth B Hymes, Tanin Intragumtornchai, Robert J Belt

Br J Haematol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.
Lecia V Sequist, Panos M Fidias, Jennifer S Temel, Tatjana Kolevska, Michael S Rabin, Robert J Belt

J Thorac Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma.
Sven de Vos, André Goy, Shaker R Dakhil, Mansoor N Saleh, Peter McLaughlin, Robert Belt

J Clin Oncol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation.
Joseph McGuirk, Gang Hao, Weijian Hou, Sunil Abhyankar, Casey Williams, Robert Belt

J Hematol Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
Leonard B Saltz, Lee S Rosen, John L Marshall, Robert J Belt, Herbert I Hurwitz

J Clin Oncol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired pure megakaryocytic aplasia: report of a single case treated with mycophenolate mofetil.
Deepti Bulchandani, Jagdish Nachnani, Robert Belt, Stuart Hinton

Am J Hematol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
Michael P Fanucchi, Frank V Fossella, Robert Belt, Ronald Natale, Panos Fidias

J Clin Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.
Nicholas Robert, Brian Leyland-Jones, Lina Asmar, Robert Belt, Des Ilegbodu

J Clin Oncol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Destructive facial T-cell lymphoma: the difficulty in diagnosis of pyoderma-like processes.
Lawrence E Gibson, Bethany R Hairston, Robert J Belt, Rokea el-Azhary

Int J Dermatol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.
Miguel A Villalona-Calero, Paul Ritch, Jose A Figueroa, Gregory A Otterson, Robert Belt

Clin Cancer Res· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: results of a phase II study.
Stephanie A Gregory, Delvyn C Case, Linda Bosserman, Debra L Litwak, William R Berry, Robert J Belt

Clin Lymphoma· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary study.
Debra Hawes, P Y Liu, Franco M Muggia, Sharon Wilczynski, Richard Cote, Robert J Belt

Gynecol Oncol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma.
Sanjiv S Agarwala, John Glaspy, Steven J O'Day, Malcolm Mitchell, John Gutheil, Robert Belt

J Clin Oncol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma.
Lyndsay Harris, Gerald Batist, Robert Belt, Douglas Rovira, Rudolph Navari

Cancer· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis